Wells Fargo’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19K | Sell |
1,529
-522,090
| -100% | -$746K | ﹤0.01% | 5745 |
|
|
2025
Q1 | $838K | Buy |
523,619
+487,313
| +1,342% | +$780K | ﹤0.01% | 3367 |
|
|
2024
Q4 | $131K | Buy |
36,306
+9,389
| +35% | +$33.8K | ﹤0.01% | 4560 |
|
|
2024
Q3 | $153K | Buy |
26,917
+1,156
| +4% | +$6.59K | ﹤0.01% | 4364 |
|
|
2024
Q2 | $119K | Buy |
25,761
+25,403
| +7,096% | +$117K | ﹤0.01% | 4469 |
|
|
2024
Q1 | $2.93K | Sell |
358
-944
| -73% | -$7.71K | ﹤0.01% | 5580 |
|
|
2023
Q4 | $7.36K | Buy |
1,302
+968
| +290% | +$5.47K | ﹤0.01% | 5459 |
|
|
2023
Q3 | $621 | Buy |
334
+23
| +7% | +$43 | ﹤0.01% | 5945 |
|
|
2023
Q2 | $855 | Sell |
311
-7,176
| -96% | -$19.7K | ﹤0.01% | 6047 |
|
|
2023
Q1 | $23.5K | Buy |
+7,487
| New | +$23.5K | ﹤0.01% | 5258 |
|
|
2022
Q4 | – | Sell |
-6,209
| Closed | -$54K | – | 7147 |
|
|
2022
Q3 | $54K | Buy |
6,209
+5,707
| +1,137% | +$49.6K | ﹤0.01% | 4614 |
|
|
2022
Q2 | $4K | Sell |
502
-18,282
| -97% | -$146K | ﹤0.01% | 5772 |
|
|
2022
Q1 | $456K | Sell |
18,784
-12,444
| -40% | -$302K | ﹤0.01% | 4199 |
|
|
2021
Q4 | $1.01M | Buy |
31,228
+2,852
| +10% | +$91.8K | ﹤0.01% | 3844 |
|
|
2021
Q3 | $1.27M | Buy |
28,376
+28,341
| +80,974% | +$1.27M | ﹤0.01% | 3831 |
|
|
2021
Q2 | $0 | Sell |
35
-5,244
| -99% | – | ﹤0.01% | 6563 |
|
|
2021
Q1 | $195K | Sell |
5,279
-33,248
| -86% | -$1.23M | ﹤0.01% | 4841 |
|
|
2020
Q4 | $1.28M | Buy |
+38,527
| New | +$1.28M | ﹤0.01% | 3780 |
|